Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial
PlexusDx's Microdose GLP-1 Protocol ($129/month) provides a gentler entry point for patients with GI sensitivity
Compounded vials have variable concentrations
5.2.6 Integrates relevant information with previous learning, experience, professional knowledge, and current practice models
Additionally, clinicians should specifically inquire about stool frequency, consistency, and timing relative to meals to identify patterns suggesting bile acid malabsorption versus medication-related effects
In these cases, clinicians may prescribe Ozempic (approved for T2DM) in place of Wegovy (approved for weight management), essentially using an FDA-approved drug for a different purpose